ARCHIVES

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981

Gallo Wins Another, To Share Hammer Prize With Three Japanese

November 30, 1984

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996